Akili, maker of a video game-like digital therapeutic for children with ADHD, hit the public markets Monday after wrapping up a merger with special-purpose acquisition company Social Capital Suvretta ...
BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili” or “Company”), maker of EndeavorRx™, the first and only prescription video game treatment, today announced $160M in combined equity and debt ...
Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It's a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback